Frederic Ris
Switzerland
Research Article
Colitis Due to Campylobacter jejuni/coli: Ceftriaxone is Not Effective
Author(s): Stephane Emonet *,Betim Redzepi ,Arnaud Riat ,Abdessalam Cherkaoui ,Benjamin A Lipsky ,Frederic Ris ,Jacques Schrenzel
Stephane Emonet *,Betim Redzepi ,Arnaud Riat ,Abdessalam Cherkaoui ,Benjamin A Lipsky ,Frederic Ris ,Jacques Schrenzel
Background: Ceftriaxone is often prescribed empirically for patients hospitalized with abdominal pain and fever. If stools culture from such a patient yields Campylobacter jejuni or Campylobacter coli (C. jejuni/coli), clinicians ask about its susceptibility to ceftriaxone, to which it is not routinely tested. We report a case of colitis that raised this question. As we couldn’t find the answer in the published literature, we investigated the sensitivity of strains of C. jejuni/coli to ceftriaxone in our hospital.
Methods: We conducted a retrospective study of all strains of C. jejuni and C. coli isolated from specimens of infected patients seen in our tertiary care university-affiliated hospital in Switzerland between March 2009 and December 2010. Campylobacter strains were identified to the species level with matrix-assisted laser de.. View More»
DOI:
10.4172/2167-7182.1000426